Article Details

CRISPR gene-editing therapy shows promise as cardiac amyloidosis treatment in early study

Retrieved on: 2024-11-16 18:02:37

Tags for this article:

Click the tags to see associated articles and topics

CRISPR gene-editing therapy shows promise as cardiac amyloidosis treatment in early study. View article details on hiswai:

Excerpt

CHICAGO — A CRISPR-Cas9-based therapy targeting the gene encoding transthyretin reduced transthyretin levels in patients with cardiac amyloidosis, ...

Article found on: www.healio.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up